Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway

Open access

Abstract

BACKGROUND: Primary sclerosing cholangitis (PSC) is 1 of the leading causes of liver transplantation (LTX) in Scandinavia, and an increasing number of PSC patients have been transplanted in Norway during the last 2 decades. This trend is partly attributable to the recently established practice in Norway of offering LTX to PSC patients with cholangiocellular dysplasia. Based on the controversy associated with this practice, we herein aimed to report the main features and outcomes of our LTX program in PSC. METHODS: The primary indication for LTX (quality of life/end-stage liver disease or suspected neoplasia) was retrospectively determined for 222 patients undergoing LTX for PSC or other autoimmune liver diseases (primary biliary cirrhosis/autoimmune hepatitis) with at least 5 years of follow-up. RESULTS: In PSC patients impaired quality of life (43.5%) and end-stage liver disease (38.4%) were the most frequent indications for LTX, whereas suspected neoplasia accounted for 18.1%. The proportion of PSC patients with manifest encephalopathy, variceal bleeding, or ascites declined over time. In patients with suspected neoplasia as the primary indication for LTX (n = 25), neoplasia was confirmed in the explanted liver in 20 patients (80%). Five-year survival rates for PSC patients transplanted between 2001 and 2009 were 91.9% for patients receiving LTX due to impaired quality of life or end-stage liver disease and 83.3% for suspected neoplasia. CONCLUSIONS: The PSC patients are increasingly listed for LTX at an earlier stage of their liver disease. In patients with suspected neoplasia before LTX, 5-year survival was acceptable, despite confirmation of neoplasia in 80% of the liver explants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/txd.0000000000000548

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 The relationship between pre- and post-pathological findings in patients with PSC undergoing LTX with a primary indication of suspected early stage neoplasia (n = 25).
FIGURE 1 The relationship between pre- and post-pathological findings in patients with PSC undergoing LTX with a primary indication of suspected early stage neoplasia (n = 25).CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 2

  1. Taniguchi, 2012, Liver transplantation in the MELD eraanalysis of the OPTNUNOS registry., Clin Transpl, 41-, 65
  2. Wiesner, 1996, Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome., Liver Transpl Surg, 2, 99

Cited by

See all 46

Metadata

Authors
Andersen, I. M., Fosby, B., Boberg, K. M., Clausen, O. P. F., Jebsen, P., Melum, E., Line, P. D., Foss, A., Schrumpf, E., & Karlsen, T. H.
Affiliations
Oslo University Hospital (NO)
Corresponding author
Fosby, Bjarte
Venue
Transplantation Direct
Published
2015-10
Volume
1
Issue
9
Pages
e39
ISSN
2373-8731 (ISSN-L)
OpenAlex
W2521381657
Cited by
45
References
33
Citations by year
2026: 7 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 3 · 2021: 2 · 2020: 5 · 2019: 4 · 2018: 5 · 2017: 3
FWCI
1.58
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Transplantation Direct (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
primary sclerosing cholangitis, liver transplantation, transplant indications, end-stage liver disease, quality of life, post-transplant survival, autoimmune liver disease, primary biliary cirrhosis, autoimmune hepatitis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway. https://app.cochat.ai/papers/10.1097/txd.0000000000000548
The paper
Andersen, I. M., Fosby, B., Boberg, K. M., Clausen, O. P. F., Jebsen, P., Melum, E., Line, P. D., Foss, A., Schrumpf, E., & Karlsen, T. H. (2015). Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway. Transplantation Direct. https://doi.org/10.1097/txd.0000000000000548

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.